The application of menisci-cruciate ligament complex in reconstructing the soft tissue defect after resection of malignant bone tumors around knee

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052249

Enrollment

Unknown

Registered

2021-10-23

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant bone tumor

Interventions

case series:menisci-cruciate ligament composite

Eligibility

Sex/Gender

All

Age

7 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with peri-knee malignant bone tumors underwent peri-knee malignancy resection and prosthetic reconstruction with soft tissue reconstruction using the meniscus-cruciate ligament complex.

Exclusion criteria

Exclusion criteria: Patients who had previously undergone resection of malignant bone tumors around the knee joint.

Design outcomes

Primary

Measure	Time frame
Postoperative wound complications;	—

Countries

China

Contacts

Public ContactYin Junqiang

The First Affiliated Hospital of Sun Yat-Sen University

yinjunqiang77@163.com+86 13822180066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026